Francia P - Search Results

1

Nitric oxide release is impaired in hypertensive individuals with familial history of stroke.

Cosentino F, Francia P, Musumeci B, De Siati L, Rao MA, De Luca N, Balla C, De Sensi F, Volpe M. Cosentino F, et al. Among authors: francia p. Am J Hypertens. 2006 Dec;19(12):1213-6. doi: 10.1016/j.amjhyper.2006.06.002. Am J Hypertens. 2006. PMID: 17161765

2

Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice.

Rordorf R, Viani S, Biffi M, Pieragnoli P, Migliore F, D'Onofrio A, Nigro G, Francia P, Ferrari P, Dello Russo A, Bisignani A, Ottaviano L, Palmisano P, Caravati F, Pisanò E, Pani A, Botto GL, Lovecchio M, Valsecchi S, Vicentini A. Rordorf R, et al. Among authors: francia p. Europace. 2023 May 19;25(5):euac234. doi: 10.1093/europace/euac234. Europace. 2023. PMID: 36932709 Free PMC article.

3

New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry.

Quartieri F, Harish M, Calò L, Ebrahim I, Fusco A, Mester S, Cauti F, Park SJ, Francia P, Giovagnoni M, Adragao P, Vezi B, Lin W, Hutson CS, Grammatico A. Quartieri F, et al. Among authors: francia p. Europace. 2023 May 19;25(5):euad068. doi: 10.1093/europace/euad068. Europace. 2023. PMID: 36935638 Free PMC article.

4

Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.

Russo V, Caturano A, Guerra F, Migliore F, Mascia G, Rossi A, Nesti M, Santobuono VE, Attena E, Tola G, Sciarra L, Conte G, Paoletti Perini A, Francia P, Dendramis G, Palamà Z, Albani S, Ottonelli Ghidini A, Calò L, D'Onofrio A, Baldi E; IBRYD Study Group. Russo V, et al. Among authors: francia p. Heart Vessels. 2023 May;38(5):680-688. doi: 10.1007/s00380-022-02204-x. Epub 2022 Nov 24. Heart Vessels. 2023. PMID: 36418560 Free PMC article.

5

Procedure, management, and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice.

De Filippo P, Migliore F, Palmisano P, Nigro G, Ziacchi M, Rordorf R, Pieragnoli P, Di Grazia A, Ottaviano L, Francia P, Pisanò E, Tola G, Giammaria M, D'Onofrio A, Botto GL, Zucchelli G, Ferrari P, Lovecchio M, Valsecchi S, Viani S. De Filippo P, et al. Among authors: francia p. Europace. 2023 Jun 2;25(6):euad158. doi: 10.1093/europace/euad158. Europace. 2023. PMID: 37350404 Free PMC article.

6

Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.

Russo V, Caturano A, Guerra F, Migliore F, Mascia G, Rossi A, Nesti M, Santobuono VE, Attena E, Tola G, Sciarra L, Conte G, Paoletti Perini A, Francia P, Dendramis G, Palamà Z, Albani S, Ottonelli Ghidini A, Calò L, D'Onofrio A, Baldi E; IBRYD Study Group. Russo V, et al. Among authors: francia p. Heart Vessels. 2023 May;38(5):689-690. doi: 10.1007/s00380-022-02228-3. Heart Vessels. 2023. PMID: 36607387 Free PMC article. No abstract available.

7

Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study.

Russo V, Caturano A, Migliore F, Guerra F, Francia P, Nesti M, Conte G, Perini AP, Mascia G, Albani S, Marchese P, Santobuono VE, Dendramis G, Rossi A, Attena E, Ghidini AO, Sciarra L, Palamà Z, Baldi E, Romeo E, D'Onofrio A, Nigro G; IBRYD Study Group. Russo V, et al. Among authors: francia p. Heart Rhythm. 2024 May;21(5):555-561. doi: 10.1016/j.hrthm.2024.01.015. Epub 2024 Jan 18. Heart Rhythm. 2024. PMID: 38242222 Free article.

8

Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy.

Cosentino F, Francia P, Volpe M. Cosentino F, et al. Among authors: francia p. J Hypertens. 2003 Mar;21(3):501-3. doi: 10.1097/00004872-200303000-00013. J Hypertens. 2003. PMID: 12640241 No abstract available.

9

Deletion of p66shc gene protects against age-related endothelial dysfunction.

Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Lüscher TF, Volpe M, Cosentino F. Francia P, et al. Circulation. 2004 Nov 2;110(18):2889-95. doi: 10.1161/01.CIR.0000147731.24444.4D. Epub 2004 Oct 25. Circulation. 2004. PMID: 15505103

10

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.

Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M. Cosentino F, et al. Among authors: francia p. Am J Hypertens. 2005 Apr;18(4 Pt 1):493-9. doi: 10.1016/j.amjhyper.2004.11.007. Am J Hypertens. 2005. PMID: 15831358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters